One partner across the cancer care continuum

Important note: Guardant Reveal and Guardant360 Tissue were developed as Laboratory Developed Tests (LDTs), and their performance characteristics determined, by the Guardant Health Clinical Laboratory in Redwood City, CA, USA, which is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical testing. These tests have not been reviewed or approved by the US FDA.

InfinityAI is not a standalone consumer product. Product features “Powered by InfinityAI” are reported as professional service and have not been cleared or approved by the US FDA.